Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boyton, R. J.
Right arrow Articles by Altmann, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyton, R. J.
Right arrow Articles by Altmann, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 10, 1765-1776, Copyright © 1998 by Oxford University Press


ARTICLES

Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice

RJ Boyton, T Lohmann, M Londei, H Kalbacher, T Halder, AJ Frater, DC Douek, DG Leslie, RA Flavell and DM Altmann
Transplantation Biology Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, UK.

Glutamic acid decarboxylase (GAD65) has been implicated as a targeted self antigen in the immune destruction of pancreatic beta cells. T cell responses to GAD65 peptides have been detected in both patients with type I diabetes and in the non-obese diabetic (NOD) mouse. To establish which GAD65 epitopes are important in the immunopathogenesis of disease we initially compared T cell responses to GAD65 epitopes in conditions of disease susceptibility and protection. T cell responses to GAD65 peptides were measured in monozygotic twin pairs selected on the basis of disease discordance and T cell recognition of immunogenic regions of GAD65. Peptides of interest were then used to immunize susceptible NOD mice and H2-E transgenic NOD mice which are protected from diabetes. A differential response to the epitope GAD65 521-535 discriminated diabetic from non-diabetic human twins as well as susceptible from protected mice. This epitope as well as GAD 505-519 induces T cell responses despite binding the type I diabetes associated HLA- DQA1*0301/DQB1*0302 product with low affinity. Since DQ-restricted T cell responses are difficult to study in humans, HLA-DQ8 transgenic mice were then used: GAD epitopes 521-535 and 505-519 induced responses in DQ8 transgenic mice and T cell lines were established. Long-term T cell lines against GAD 505-519 were HLA-DQ restricted, and responded to peptide with a strong IFN-gamma and IL-10 response. The findings implicate GAD 521-535 as a possible target peptide in pathogenesis and are compatible with a model whereby self-reactive T cells specific for low-affinity peptide-MHC complexes may escape thymic negative selection.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
K. Y. Chang and E. R. Unanue
Prediction of HLA-DQ8 {beta} cell peptidome using a computational program and its relationship to autoreactive T cells
Int. Immunol., June 1, 2009; 21(6): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Faulkner, D. M. Altmann, S. Ellmerich, I. Huhtaniemi, G. Stamp, and S. Sriskandan
Sexual Dimorphism in Superantigen Shock Involves Elevated TNF-{alpha} and TNF-{alpha} induced Hepatic Apoptosis
Am. J. Respir. Crit. Care Med., September 1, 2007; 176(5): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. J. Boyton, S. Davies, C. Marden, C. Fantino, C. Reynolds, K. Portugal, H. Dewchand, and D. M. Altmann
Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread
Int. Immunol., September 1, 2005; 17(9): 1157 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-K. Kim, K. V. Tarbell, M. Sanna, M. Vadeboncoeur, T. Warganich, M. Lee, M. Davis, and H. O. McDevitt
Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells
PNAS, September 28, 2004; 101(39): 14204 - 14209.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette
The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity
J. Immunol., November 1, 2002; 169(9): 5098 - 5108.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Unnikrishnan, D. M. Altmann, T. Proft, F. Wahid, J. Cohen, J. D. Fraser, and S. Sriskandan
The Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of Streptococcus pyogenes
J. Immunol., September 1, 2002; 169(5): 2561 - 2569.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Boyton, N. Zaccai, E. Y. Jones, and D. M. Altmann
CD4 T Cells Selected by Antigen Under Th2 Polarizing Conditions Favor an Elongated TCR{alpha} Chain Complementarity-Determining Region 3
J. Immunol., February 1, 2002; 168(3): 1018 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. E. Herman, R. M. Tisch, S. D. Patel, S. L. Parry, J. Olson, J. A. Noble, A. P. Cope, B. Cox, M. Congia, and H. O. McDevitt2
Determination of Glutamic Acid Decarboxylase 65 Peptides Presented by the Type I Diabetes-Associated HLA-DQ8 Class II Molecule Identifies an Immunogenic Peptide Motif
J. Immunol., December 1, 1999; 163(11): 6275 - 6282.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.